Affordable Access

Prostate cancer.

Authors
Type
Published Article
Journal
Endocrinology and Metabolism Clinics of North America
0889-8529
Publisher
Elsevier
Publication Date
Volume
23
Issue
4
Pages
809–824
Identifiers
PMID: 7705321
Source
Medline
License
Unknown

Abstract

Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years. The tumor remains refractory to conventional chemotherapeutic agents. True containment of this disease will require novel strategies of diagnosis, biologic assessment, and therapy.

Statistics

Seen <100 times